Literature DB >> 27717958

Molecular modelling and molecular dynamics of CFTR.

Isabelle Callebaut1, Brice Hoffmann2, Pierre Lehn3, Jean-Paul Mornon2.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a member of the ATP-binding cassette (ABC) transporter superfamily that functions as an ATP-gated channel. Considerable progress has been made over the last years in the understanding of the molecular basis of the CFTR functions, as well as dysfunctions causing the common genetic disease cystic fibrosis (CF). This review provides a global overview of the theoretical studies that have been performed so far, especially molecular modelling and molecular dynamics (MD) simulations. A special emphasis is placed on the CFTR-specific evolution of an ABC transporter framework towards a channel function, as well as on the understanding of the effects of disease-causing mutations and their specific modulation. This in silico work should help structure-based drug discovery and design, with a view to develop CFTR-specific pharmacotherapeutic approaches for the treatment of CF in the context of precision medicine.

Entities:  

Keywords:  ABC transporte; ABCC7; Cystic fibrosis; Ion channel; Modulators; Mutations

Mesh:

Substances:

Year:  2016        PMID: 27717958     DOI: 10.1007/s00018-016-2385-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  198 in total

1.  Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.

Authors:  Yonjung Kim; Marc O Anderson; Jinhong Park; Min Goo Lee; Wan Namkung; A S Verkman
Journal:  Mol Pharmacol       Date:  2015-07-14       Impact factor: 4.436

2.  Crystal structures of a polypeptide processing and secretion transporter.

Authors:  David Yin-wei Lin; Shuo Huang; Jue Chen
Journal:  Nature       Date:  2015-07-23       Impact factor: 49.962

Review 3.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

4.  A potentiator induces conformational changes on the recombinant CFTR nucleotide binding domains in solution.

Authors:  Elena Galfrè; Lauretta Galeno; Oscar Moran
Journal:  Cell Mol Life Sci       Date:  2012-07-03       Impact factor: 9.261

5.  Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics.

Authors:  Jean-Paul Mornon; Brice Hoffmann; Slavica Jonic; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2014-10-07       Impact factor: 9.261

6.  Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator.

Authors:  M H Akabas; C Kaufmann; T A Cook; P Archdeacon
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

7.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

8.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

9.  Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain.

Authors:  Kazuhiro Mio; Toshihiko Ogura; Muneyo Mio; Hiroyasu Shimizu; Tzyh-Chang Hwang; Chikara Sato; Yoshiro Sohma
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

10.  Alignment of transmembrane regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Wuyang Wang; Yassine El Hiani; Paul Linsdell
Journal:  J Gen Physiol       Date:  2011-07-11       Impact factor: 4.086

View more
  12 in total

1.  Beyond cystic fibrosis transmembrane conductance regulator (CFTR) single channel kinetics: implications for therapeutic intervention.

Authors:  Carmel M McNicholas
Journal:  J Physiol       Date:  2017-02-15       Impact factor: 5.182

Review 2.  NM23 proteins: innocent bystanders or local energy boosters for CFTR?

Authors:  Richmond Muimo; Hani Mm Alothaid; Anil Mehta
Journal:  Lab Invest       Date:  2017-12-18       Impact factor: 5.662

Review 3.  Transformative therapies for rare CFTR missense alleles.

Authors:  Kathryn E Oliver; Sangwoo T Han; Eric J Sorscher; Garry R Cutting
Journal:  Curr Opin Pharmacol       Date:  2017-10-13       Impact factor: 5.547

4.  Molecular Dynamics and Theratyping in Airway and Gut Organoids Reveal R352Q-CFTR Conductance Defect.

Authors:  Sharon L Wong; Nikhil T Awatade; Miro A Astore; Katelin M Allan; Michael J Carnell; Iveta Slapetova; Po-Chia Chen; Jeffry Setiadi; Elvis Pandzic; Laura K Fawcett; John R Widger; Renee M Whan; Renate Griffith; Chee Y Ooi; Serdar Kuyucak; Adam Jaffe; Shafagh A Waters
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

Review 5.  Ion Channel Modulators in Cystic Fibrosis.

Authors:  Martina Gentzsch; Marcus A Mall
Journal:  Chest       Date:  2018-05-08       Impact factor: 9.410

6.  Combining theoretical and experimental data to decipher CFTR 3D structures and functions.

Authors:  Brice Hoffmann; Ahmad Elbahnsi; Pierre Lehn; Jean-Luc Décout; Fabio Pietrucci; Jean-Paul Mornon; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

7.  Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.

Authors:  Sangwoo T Han; Andras Rab; Matthew J Pellicore; Emily F Davis; Allison F McCague; Taylor A Evans; Anya T Joynt; Zhongzhou Lu; Zhiwei Cai; Karen S Raraigh; Jeong S Hong; David N Sheppard; Eric J Sorscher; Garry R Cutting
Journal:  JCI Insight       Date:  2018-07-26

Review 8.  Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications.

Authors:  Marcus A Mall; Nicole Mayer-Hamblett; Steven M Rowe
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

9.  Functional organization of cytoplasmic portals controlling access to the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel pore.

Authors:  Man-Song Li; Elizabeth A Cowley; Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

Review 10.  Personalized or Precision Medicine? The Example of Cystic Fibrosis.

Authors:  Fernando A L Marson; Carmen S Bertuzzo; José D Ribeiro
Journal:  Front Pharmacol       Date:  2017-06-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.